Do you have $10,000 to put into the share market and a penchant for ASX growth shares?

If you do, then it could be worth considering the three named in this article that brokers rate as buys. Here’s why they could be top picks:

Breville Group Ltd (ASX: BRG)

The first ASX growth share to consider is Breville Group. It sells kitchen appliances, which is a category that many investors assume is mature. But Breville’s edge lies in how it treats appliances as premium, design-led products rather than commodities.

The company has spent years building brand loyalty in key global markets, particularly North America and Europe. Once consumers buy into the Breville ecosystem, repeat purchases and word-of-mouth do much of the heavy lifting. That brand-led approach allows the company to command higher prices and protect margins.

In addition, Breville has built a very strong position in the at-home coffee market, which continues to grow at a strong rate. Combined with the rest of the business, Breville could be well-placed for growth over the next decade and beyond.

Citi currently has a buy rating and $36.03 price target on Breville’s shares.

NextDC Ltd (ASX: NXT)

Another ASX growth share to consider is NextDC. It sits behind the scenes of the digital economy. Its data centres provide the physical infrastructure that cloud platforms, enterprises, and governments rely on to store and move data securely.

What makes NextDC interesting from a growth perspective is that demand does not arrive evenly. Large contracts tend to come in waves as customers scale up capacity or enter new regions. That can make short-term results look uneven, even while the long-term trajectory remains intact.

As data usage, cloud adoption, and AI workloads continue to grow, the need for secure, well-located data centres is unlikely to fade. NextDC’s expanding footprint positions it to benefit as customers’ infrastructure requirements become larger and more complex.

Macquarie is bullish on this one and has an outperform rating and $22.30 price target on its shares.

Telix Pharmaceuticals Ltd (ASX: TLX)

A final ASX growth share to look at is Telix Pharmaceuticals. It develops radiopharmaceuticals used in cancer diagnosis and treatment, combining biotechnology with specialised manufacturing and distribution.

What sets Telix apart is that it is transitioning from a development-stage business to a commercial one. As products move from approval into wider clinical use, revenue can scale quickly without the need to reinvent the underlying platform each time.

This creates a growth profile that is tied more to clinical adoption and market penetration than traditional economic cycles. For investors, that introduces volatility, but it also offers exposure to a part of healthcare where innovation can translate directly into earnings growth.

Bell Potter has a buy rating and $23.00 price target on its shares.

The post Where to invest $10,000 in ASX growth shares appeared first on The Motley Fool Australia.

More reading

• Breville shares fall despite a result brokers have welcomed
• Breville Group posts record half-year sales and lifts dividend
• 5 things to watch on the ASX 200 on Thursday
• The ASX 200 shares I’d be comfortable holding in an SMSF
• Macquarie shares taking off today as assets under management top $736 billion

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in Temple & Webster Group Ltd (ASX: TPW) have been absolutely smashed on Thursday.

At the time of writing, the Temple & Webster share price is down a brutal 25.49% to $8.45 following the release of its half-year results.

That leaves the stock down around 40% since the start of 2026, wiping out a huge chunk of its recent gains.

Let’s dive into what Temple & Webster actually reported that triggered such a heavy sell-off.

Revenue jumps 20% as market share grows

Temple & Webster reported H1 FY26 revenue of $376 million, up 20% on the prior corresponding period. Management said growth accelerated through the half, with revenue up 20% year-on-year from 1 January to 9 February.

Active customers climbed 14% to 1.4 million, while repeat customers now account for 62% of total orders. Revenue from exclusive products increased to 49% of total revenue, up from 45% a year ago.

EBITDA came in at $13.5 million, or $14.9 million excluding New Zealand start-up costs, representing a margin of around 4%.

So why is the share price crashing today?

The issue appears to come down to margins and expectations.

Despite strong top-line growth, delivered margin declined slightly to 30.5%. While marketing costs improved as a percentage of revenue, investors may have been hoping for stronger operating leverage at this stage of the cycle.

Temple & Webster reaffirmed its FY26 EBITDA margin guidance of 3% to 5%. While that range remains unchanged, it suggests profitability will stay relatively modest compared to the company’s long-term ambitions.

There was also a sharp decline in net profit before tax, which fell 28% to $7.4 million. Depreciation and amortisation increased materially during the half, impacting the bottom line.

Balance sheet remains strong

Temple & Webster ended the half with $161 million in cash and no debt. The company generated $23 million in free cash flow and continues to run an on-market share buyback.

Management reiterated its medium-term target of reaching $1 billion in annual revenue and said it remains on track.

It is also worth remembering that Temple & Webster has historically traded on a premium earnings multiple. With expectations already running high, even a small miss was enough to spark heavy selling.

Foolish takeaway

Today’s 25% plunge shows just how sensitive high-growth retail stocks can be to any hint of margin pressure.

Temple & Webster is still growing revenue at a healthy rate and building market share. However, with the share price already down around 40% this year, investors are clearly demanding stronger evidence of margin expansion and bottom-line growth.

The post Temple & Webster shares just crashed 25%. What on earth just happened? appeared first on The Motley Fool Australia.

More reading

• Temple & Webster H1 FY26 earnings: Revenue jumps 20% as market share grows
• 3 of my high-conviction ASX 200 share picks for February
• 3 ASX stocks poised to ride Australia’s renovation wave
• 2 ASX shares that could be overdue for a new year jump
• 2 excellent ASX All Ords stocks I’d buy today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I think it is fair to say that CSL Ltd (ASX: CSL) shares have been having a difficult time of late.

Due to the release of a soft half-year result and the shock exit of its CEO the day before, the biotech giant’s shares have crashed to multi-year lows.

Is this a buying opportunity for investors? Let’s see what Bell Potter is saying about the struggling blue chip.

What is the broker saying?

Bell Potter was not overly impressed with CSL’s performance during the first half, highlighting that the key CSL Behring business weighed on its results. It said:

Key call outs from the various segments include: (1) Ig sales down -4% on pcp and 5% below VA consensus, resulting in a reduction to our full-year Ig sales growth to +3%. (2) Behring gross margin was effectively flat and guided to minimal, if any, increase [for] the full-year FY26. A return to pre-Covid GM for Behring is looking slower and more difficult with each passing result.

(3) Seqirus was a positive surprise following US market share capture and launches into Germany and France; (4) Vifor nephrology sales was a positive surprise, albeit benefited by TDAPA tailwinds lasting to Dec 2026; and (5) Iron sales continue to decline and are unlikely to turnaround in the face of active generic competition in the EU and looming competition in the US.

Are CSL shares good value yet?

According to the note, the broker thinks investors should be keeping their powder dry for the time being.

In response to the results, Bell Potter has retained its hold rating on CSL shares with a reduced price target of $175.00 (from $195.00).

Though, based on its current share price of $154.53, this implies potential upside of 13% for investors over the next 12 months.

Commenting on its hold recommendation, Bell Potter said:

The reduction to forecasts lowers our DCF valuation, while we have reduced the PE multiple from 17x to 16x considering the worsening earnings growth outlook and uncertainty around FY26 guidance. The net effect is a 10% reduction in PT to $175 from $195.

We maintain our HOLD recommendation. CSL now trades on an underlying PE of 16.5x in FY27, well below its historical average but remains above the global biopharma avg of ~15x. It faces the daunting prospect of hiring a new CEO to re-invigorate a lacklustre growth outlook in the face of headwinds on multiple fronts.

The post Are CSL shares a buy after this week’s brutal selloff? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Beach Energy, CSL, and Pro Medicus shares
• 5 things to watch on the ASX 200 on Thursday
• Why ASX, CSL, GQG, and Meteoric Resources shares are sinking today
• CSL shares crash 12% on half-year results and shock CEO exit
• Here’s everything you need to know about CSL’s upcoming dividend

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shares in Breville Group Ltd (ASX: BRG) have fallen on Thursday after the company delivered record first-half revenue, with the effort also applauded by brokers.

The appliance manufacturer said in a statement to the ASX on Thursday that first-half revenue had come in at $1.09 billion, up 10.1% on the previous corresponding period, while net profit was up just 0.7% to $98.2 million.

The company also boosted its interim dividend by 1 cent to 19 cents, fully franked.

Management spruiks solid result

Breville Chief Executive Officer Jim Clayton said the company had performed well in challenging times.

He went on to say:

Breville delivered 10.1% revenue growth, another record half, while executing two transformative programs simultaneously – driving the manufacturing diversification of our 120-volt portfolio and leaning into the front edge of our enterprise-wide AI program.  Coffee continued to lead, delivering double-digit revenue growth. Our new product development pipeline again contributed materially to performance, with strong launches across espresso and cooking. Beanz continued its rapid growth trajectory, scaling across four countries with the infrastructure and processes now proven to support further growth.

Mr Clayton said the company’s newest markets – Mexico, China, the Middle East, and Korea – “collectively grew over 50%, further validating geographic expansion as an important growth lever”.

Mr Clayton added:

What differentiates this half is the deliberate acceleration of our AI transformation. We’re implementing AI enterprise-wide, across every function, at pace. This is Phase IV of Breville’s evolution—not a point solution or pilot program, but a multi-layered, systemic transformation. We’re building this capability internally with our own team, and I am personally training every office, globally, because organisational readiness matters as much as technology readiness.

Mr Clayton said the company also had an improved net debt position despite challenges such as having to pay $42 million in US tariffs.

On the outlook, the company said it expected earnings for the full year to be slightly ahead of FY25, “given the magnitude of the US tariff increases that the group’s value chain is absorbing”.

Brokers like what they see

Jarden analysts ran their ruler over the results and said it was a “solid result overall”, with FY26 guidance “a touch ahead” of consensus.

Jarden said their view was that FY26 was a transition year for the company, with FY27 shaping up to be a double-digit earnings growth year.

RBC Capital Markets said the result was broadly in line with market expectations.

They added:

We expect today’s result to be taken positively by the market, with the provision of guidance enhancing visibility on tariff impacts and largely de-risking the near-term earnings outlook.

Breville shares were 2% lower at $32.74 by mid-morning.

The post Breville shares fall despite a result brokers have welcomed appeared first on The Motley Fool Australia.

More reading

• Breville Group posts record half-year sales and lifts dividend
• 5 things to watch on the ASX 200 on Thursday
• 2 ASX 200 shares that could be top buys for growth
• What the stronger Australian dollar means for your shares
• 3 no-brainer ASX shares to consider buying now with just $100

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Pro Medicus Ltd (ASX: PME) shares are having a day to forget on Thursday.

In morning trade, the health imaging technology company’s shares are down almost 20% to $136.75.

This follows the release of the company’s half-year results.

Pro Medicus shares crash on results day

For the six months ended 31 December, Pro Medicus reported a 28.4% increase in revenue to $124.8 million. This was underpinned by six key implementations in the half, all of which are cloud-based.

Pro Medicus’ underlying EBIT margin increased to 73% from 72% a year earlier. This underlying a 29.7% lift in underlying profit before tax to a record of $90.7 million.

Reported net profit after tax came in at $171.2 million, which is up 230.9% on the prior corresponding period. This reflects unrealised gains from its investment in 4DMedical Ltd (ASX: 4DX).

Commenting on the company’s performance, CEO Dr Sam Hupert said:

Our profits continue to grow strongly even though our biggest implementation during the period in Trinity Cohort 1 went live towards the end of October so had limited impact on the half. Importantly, our margins also grew, and we made more sales in this half than we used to make in a full year just 2 years ago. Most contracts were for the full stack of Visage products – Viewer, Workflow and Archive and two also included our cardiology offering making them full stack +1, a trend we see continuing.

What about the AI threat?

In an accompanying interview, Dr Hupert spoke at length about the threat of AI on the company’s business.

The good news is that he doesn’t believe its Visage software is going to be replaced by AI. He explains:

The second concern is a belief held by some that new AI tools will radically disrupt software development with Vibe coding helping destroy the “IP moat” of all software and SaaS providers. They claim anyone will be able to use AI tools to write industry grade software in a fraction of the time.

This, in our view, is an overly simplistic generalisation, one that certainly doesn’t apply to us. Visage 7 was built from the ground up using our own proprietary technology. It is not based on some readily available tool kit or platform. It is a very specialised, highly technical, patented suite of software that incorporates more than 30 years of domain knowledge; it is not a product that can be readily replicated with or without AI. We have not left a roadmap for others to follow.

The post Pro Medicus shares crash 20% on results day appeared first on The Motley Fool Australia.

More reading

• Pro Medicus interim earnings surge on record profits
• Buy, hold, sell: Beach Energy, CSL, and Pro Medicus shares
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• 5 amazing ASX shares that could build serious wealth for investors

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The MFF Capital Investments Ltd (ASX: MFF) share price is in focus after the company reported net profit after tax of $209.7 million for the half year to 31 December 2025 and lifted its fully franked interim dividend to 10 cents per share, up from 8 cents a year earlier.

What did MFF Capital Investments report?

• Total revenue and other income fell 44% to $308.9 million (Dec 2024: $551.8 million)
• Net profit after tax was down 45% to $209.7 million (Dec 2024: $381.5 million)
• Pre-tax net tangible assets (NTA) increased to $5.279 per share, up from $5.021 at 30 June 2025
• Post-tax NTA rose to $4.432 per share (30 June 2025: $4.167)
• Fully franked interim dividend declared at 10 cents per share, with intention to raise the next dividend to 11 cents
• Net assets up 7% to $2.61 billion over the half-year

What else do investors need to know?

MFF’s board flagged its intention to further increase the next six-monthly dividend payment to 11 cents per share, supported by healthy franking credit reserves. The company’s net assets at 31 December 2025 grew to $2.61 billion, reflecting steady capital appreciation despite a year of choppy global equity markets and a weaker US dollar impacting reported profits.

During the half, MFF made investments to become fully autonomous following the end of its long-term service arrangements with Magellan. The firm now operates with a team of 17 and has internalised all key operational and investment management functions, seeking long-term compounding for shareholders.

What’s next for MFF Capital Investments?

Looking ahead, MFF aims to deliver sustained growth in net tangible assets and dividends. The company is positioned for future growth, having completed the transition to operational independence and invested in expanding in-house capabilities. MFF states its focus remains on holding a concentrated portfolio of high-quality global companies and seeking enduring capital growth through disciplined, long-term investing.

MFF will continue to keep shareholders informed with regular NTA updates, noting that returns will reflect ongoing market volatility and currency movements. The next dividend uplift is flagged for the period to June 2026, backed by a substantial franking credit balance.

MFF Capital Investments share price snapshot

Over the past 12 moths, MFF Capital Investments shares have declined 1%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post MFF Capital Investments results: Profit falls but dividend rises for H1 FY26 appeared first on The Motley Fool Australia.

More reading

• South32 lifts profit and dividend in strong first half
• Lendlease announces CEO succession as Tony Lombardo steps down
• Temple & Webster H1 FY26 earnings: Revenue jumps 20% as market share grows
• Paladin Energy shares in focus after uranium sales fuel revenue jump
• Pro Medicus interim earnings surge on record profits

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Mff Capital Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The South32 Ltd (ASX: S32) share price is in focus after the diversified miner reported a 29% jump in profit to US$464 million and announced a fully-franked interim dividend of US 3.9 cents per share. Underlying earnings rose 16% to US$435 million, with strong contributions from higher base and precious metal prices.

What did South32 report?

• Revenue from continuing operations: US$2,809 million (down 3% on H1 FY25)
• Profit after tax attributable to members: US$464 million (up 29%)
• Underlying EBITDA: US$1,107 million (up 9%)
• Underlying earnings attributable to members: US$435 million (up 16%)
• Fully-franked interim dividend: US 3.9 cents per share (up 15%)
• Net tangible assets per share: US$2.02 (up from US$1.93 at 30 June 2025)

What else do investors need to know?

South32 increased its total capital management program by US$100 million to US$2.6 billion, with US$209 million left to return to shareholders by February 2027. H1 FY26 production and operating unit cost guidance remains unchanged across operated assets, reinforcing the company’s disciplined operational approach.

During the half, South32 completed divestments of Cerro Matoso and Illawarra Metallurgical Coal, focusing its portfolio on critical base metals. The Mozal Aluminium smelter will move to care and maintenance in March 2026 due to ongoing electricity supply issues in Mozambique.

What did South32 management say?

Chief Executive Officer Graham Kerr said:

Our consistent operating performance and higher base and precious metals prices underpinned strong financial results for the half. We delivered Underlying EBITDA of US$1.1B and 16 per cent growth in Underlying earnings to US$435M. We have today announced a fully-franked interim ordinary dividend of US 3.9 cents per share (US$175M) in respect of the December 2025 half year. Reflecting our strong financial position and positive outlook for the business, we have also increased our capital management program by US$100M to US$2.6B, with US$209M remaining to be returned to shareholders.

What’s next for South32?

Looking ahead, South32’s production and unit cost guidance is unchanged for FY26, with a steady focus on safe and reliable operations. The group is prioritising the growth of its base metals business ― with significant investment at the Hermosa Taylor zinc-lead-silver project in the USA and life extension options underway at Cannington.

South32 continues to explore new base metals projects and ramp up brownfield developments. Management expects to maintain their capital management approach and support returns to shareholders, while also seeking further value in next-generation mining and development projects.

South32 share price snapshot

Over the past 12 months, South32 shares have risen 41%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post South32 lifts profit and dividend in strong first half appeared first on The Motley Fool Australia.

More reading

• MFF Capital Investments results: Profit falls but dividend rises for H1 FY26
• Lendlease announces CEO succession as Tony Lombardo steps down
• Temple & Webster H1 FY26 earnings: Revenue jumps 20% as market share grows
• Paladin Energy shares in focus after uranium sales fuel revenue jump
• Pro Medicus interim earnings surge on record profits

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Northern Star Resources Ltd (ASX: NST) share price is charging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) gold stock closed yesterday trading for $28.26. In morning trade on Thursday, shares are changing hands for $29.35, up 3.9%.

For some context, the ASX 200 is up 0.3% at this same time.

Taking a step back, the Northern Star share price has gained a market-beating 60.4% over the past 12 months. That’s atop delivering two dividends (partly franked) totalling 55 cents per share.

And investors who waded in and bought the ASX 200 gold miner at its one-year closing lows of $15.30 on 1 August will be sitting on gains of 91.8% at the time of writing.

Part of that strong outperformance has been driven by the rocketing gold price. While down from the record highs notched in late January, the yellow metal is currently fetching US$5,097 per ounce. That sees the gold price up more than 52% over 12 months.

Of course, Northern Star has hardly been sitting idle.

Here’s what’s grabbing investor interest again today.

Northern Star share price jumps on 49% profit surge

The ASX 200 gold miner released its half-year results covering the six months to 31 December before market open this morning (H1 FY 2026).

The Northern Star share price looks to be getting a boost, with the miner reporting a 19% year-on-year boost in half-year revenue to $3.41 billion. The company credited the revenue surge to the 31% increase in its average realised gold prices.

Underlying earnings before interest, taxes, depreciation and amortisation (EBITDA) also enjoyed a big lift, rising 34% from H1 FY 2025 to $1.88 billion. Earnings were buoyed by higher gold prices but hindered by increased mining costs.

On the bottom line, Northern Star delivered underlying net profit after tax (NPAT) of $760 million. That’s up 49% year on year.

With profits surging, management declared a conservative fully-franked interim dividend of 25 cents per share. That’s in line with last year’s interim dividend, although that one came without franking credits.

As at 31 December, the miner held net cash of $293 million, with cash and bullion holdings totalling $1.18 billion.

What did management say?

Commenting on the half-year results helping lift the Northern Star share price today, managing director Stuart Tonkin said:

This first half result demonstrates the resilience and growing returns we are embedding in our business, which allowed the board to declare a 25 cents per share interim dividend despite a soft operating performance.

Our balance sheet remains in a net cash position notwithstanding the significant investments we are making to transform Northern Star into a lowest-half global cost producer.

The post Up 92% since August, why is the Northern Star share price lifting off again today? appeared first on The Motley Fool Australia.

More reading

• Northern Star Resources lifts profit 41%, maintains dividend after active half
• 5 things to watch on the ASX 200 on Thursday
• I would skip Northern Star shares and buy these ASX stocks
• 5 things to watch on the ASX 200 on Wednesday
• Experts name 3 ASX 200 giants to sell today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Lendlease Group (ASX: LLC) share price is in focus after the developer announced CEO Tony Lombardo will step down in August 2026. The company revealed a leadership transition is underway, following the successful implementation of its refreshed strategy.

What did Lendlease report?

• CEO and Managing Director Tony Lombardo to leave after five years in the role
• Succession plan initiated, with executive search firm engaged to find new CEO
• Strategic reset of the Group has been largely executed
• Focus remains on long-term value creation for people, customers, and securityholders

What else do investors need to know?

Lombardo, who has been with Lendlease for 18 years, will depart after overseeing a period of significant change. The Board says the strategic reset — including efforts to simplify the portfolio, restore the balance sheet, and position for future growth — is now “embedded”.

Chairman John Gillam described FY27 as an “inflection point” for the business, suggesting that this is the right opportunity for new leadership. The transition process will prioritise stability, with Lombardo staying until August 2026 to support an orderly handover.

An international executive search firm has been appointed to identify the next Group CEO, with further updates to be provided to the market as the process unfolds.

What’s next for Lendlease?

Lendlease is entering the next phase of its strategy, with FY27 signalled as a turning point for the Group. The company is aiming to build on its recent foundations and drive long-term growth.

Investors can expect more updates on the CEO search and further details on business execution as the leadership transition is managed across the coming 18 months.

Lendlease share price snapshot

Over the past 12 months, Lendlease shares have declined 29%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 6% over the same period.

View Original Announcement

The post Lendlease announces CEO succession as Tony Lombardo steps down appeared first on The Motley Fool Australia.

More reading

• Temple & Webster H1 FY26 earnings: Revenue jumps 20% as market share grows
• Paladin Energy shares in focus after uranium sales fuel revenue jump
• Pro Medicus interim earnings surge on record profits
• AMP FY25 result: 21% profit lift and higher AUM
• Orora earnings: robust half-year profit growth and outlook

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Wildcat Resources Ltd (ASX: WC8) has this week reported drilling results from its Bolt Cutter Central discovery in Western Australia, with lithium mineralisation present in all drill holes to date.

The company drilled three diamond holes for metallurgical purposes and is continuing with drilling to hopefully expand the scale of the discovery.

A reverse circulation drilling program is also scheduled to start late in the current quarter, the company said in its statement to the ASX.

Dual deposit development a possibility

The Bolt Cutter prospect is just 10km west of Wildcat’s Tabba Tabba project, for which the company released a prefeasibility study last year, indicating a probable 17-year mine life.

The company said this week that the lithium mineralisation at Bolt Cutter was quite coarse, which could be suited to a different processing method.

As the company explained:

Each of the completed diamond holes intersected mineralisation interpreted to contain spodumene and other lithium bearing minerals. Encouragingly, diamond core samples indicate that some interpreted spodumene crystals are quite coarse, exceeding 100mm in length. While the primary focus of the metallurgical test work is to assess the suitability of the pegmatite for processing through the existing Tabba Tabba flowsheet, due to the observations of coarse interpreted spodumene, the applicability of a dense media separation (DMS) workflow will also be evaluated.

Shaw and Partners have had a look at the results and said in a research note to clients that they were encouraging.

As they said:

Results to date demonstrate strong potential for Bolt Cutter to grow in scale both laterally and at depth. Bolt Cutter is likely to be a key component of Wildcat’s two-pronged strategy of exploration and development, with organic growth from discoveries providing a clear pathway for integration into broader development plans. Wildcat is moving quickly toward production, having made its major discovery on already granted mining leases. This unusual status, combined with a signed Native Title Agreement, significantly truncates the regulatory and permitting timeline, allowing the company to target first production in 2028. This will allow Wildcat to capitalise on the current lithium price cycle as the market moves into deficit later this decade.

Shaw and Partners said the company should be well-placed to be in production in time to feed into what was an “overwhelmingly bullish outlook for lithium demand, fuelled not only by the global transition to electric vehicles, but also by the rapidly increasing power requirements of AI data centres and utility-scale energy storage systems”.

Shaw has a price target of $1.20 on Wildcat shares, compared with the current price of 38.5 cents, which would be a 211.7% return if achieved.

The post This lithium developer could deliver better than 200% upside Shaw and Partners says appeared first on The Motley Fool Australia.

More reading

• Why Capstone Copper, Catalyst Metals, DroneShield, and Wildcat shares are rising today
• Guess which surging ASX All Ords lithium share is smashing the benchmark again today
• Up 240% since June, guess which ASX All Ords lithium share is jumping higher again on Tuesday

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.